Disclosure Panels Details Page

Wilms Tumor Panel - Disclosures as of 04/19/2024

Panel Member
(Spouse/Domestic Partner/Dependent)
Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty Date Completed
Amy Armstrong MD None Alexion Pharmaceuticals, Inc. None None 03/04/2024
Jamie Aye MD None None None None 01/15/2024
Frank Balis MD Day One Pharmaceuticals
Eli Lilly and Company
MedPacto
None None None 02/12/2024
Daniel Benedetti MA,MD None None None None 01/05/2024
Marian Birkeland PhD None None None None 04/02/2024
Nicole Blankenhorn None None None None 03/04/2024
Brandon Brown MD None None None None 09/06/2023
Erin Brown MD None None None None 02/12/2024
Shelly Cook MD None None None None 08/31/2023
Ami Desai MSCE,MD None Recordati None None 02/05/2024
Jasreman Dhillon MD None None None None 06/26/2023
Douglas Fair MS,MD None None None None 01/16/2024
Daniel Geynisman MD None Bristol Myers Squibb
Exelixis Inc.
Janssen Pharmaceutica Products, LP
Merck & Co., Inc.
None None 06/20/2023
Daniel Green MD None None None None 03/11/2024
Kristina Gregory MSN,RN None None None None 01/10/2024
Evelyn Handel PharmD,BCPS,BCOP None None None None 02/02/2024
Erin Hesler None None None None 12/22/2023
Susan Hiniker MD None None None None 01/29/2024
Rama Jasty-Rao MD None None None None 02/06/2024
Marissa Just MD None None None None 02/15/2024
Kathleen Kieran MD None Expert witness for defendant in Oregon malpractice trial None None 12/17/2023
Chi Lin PhD,MD BioMimelix JV, LLC None None None 04/25/2023
Daniel Lui PharmD,BCPPS None None None None 04/09/2024
Iain MacEwan MD None None None None 02/01/2024
Julian Martinez-Agosto PhD,MD,FABMG None None None None 04/03/2024
Sarah Montgomery None None None None 01/26/2024
Elizabeth Mullen MD Childrens Oncology Group
I am on international data safety monitoring board for Randomet2017 EudraCT-No.: 2018-000533-13 Randomized multi-centre open-label non-inferiority phase 3 clinical trial for patients with a stage IV child-hood renal tumour comparing upfront Vincristine, Actinomycin-D and Doxorubicin (VAD, standard a
I am on SAB for Camp Casco, camp for children with cancer None None 10/23/2023
Erin Murphy MD None None None None 09/06/2023
Navin Pinto MD None None None None 05/22/2023
Donna Powell CMD,DHSc,RT(T) None None None None 03/13/2024
Mark Ranalli MD None None None None 01/16/2024
Daniel Rhee MD,FACS,MPH None None None None 03/11/2024
Denise Rokitka MD,MPH None None None None 02/09/2024
Samantha Tamburro OCN,RN,BSN None None None None 12/08/2023
Elisabeth (Lisa) Tracy MD None None None None 09/15/2023
Tamara Vern-Gross DO None None None None 02/10/2024
Michael Walsh MD None None None None 09/15/2023
Amy Walz MD None None None None 04/01/2024
Jonathan Wickiser MD None None None None 11/22/2023
Janet Yoon MD None None None None 03/25/2024
Matthew Zapala PhD,MD None None None None 08/21/2023